Patents Assigned to PowerJect Vaccines Inc.
  • Patent number: 6200959
    Abstract: An approach to genetic vaccine methodology is described. A genetic construction encoding antigenic determinants of a filovirus is transfected into cells of the vaccinated individuals using a particle acceleration protocol so as to express the viral antigens in healthy cells to produce an immune response to those antigens.
    Type: Grant
    Filed: December 4, 1996
    Date of Patent: March 13, 2001
    Assignee: PowerJect Vaccines Inc.
    Inventors: Joel R. Haynes, Connie S. Schmaljohn, Deborah L. Fuller, Alan Schmaljohn, Peter B. Jahrling